AbCellera Biologics, Inc. (ABCL)

11.94 -0.52 (-4.17%) USD  |  NASDAQ  |  Nov 11, 16:00
11.98 +0.04 (+0.34%) After-Hours: 17:34
More

AbCellera Biologics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for ABCL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2023. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
Date Value
December 31, 2023 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
MindWalk Holdings Corp. Upgrade
Agilent Technologies, Inc. Upgrade
Bio-Rad Laboratories, Inc. Upgrade
Bruker Corp. Upgrade
Azenta, Inc. Upgrade